Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001193805-25-000922
Filing Date
2025-06-20
Accepted
2025-06-20 17:15:28
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 e664637_4a-duane.html 4/A  
1 e664637_4a-duane.xml 4/A 4158
  Complete submission text file 0001193805-25-000922.txt   5721
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VITAL THERAPIES, INC. 15010 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128
Business Address
Nash Duane (Reporting) CIK: 0001591098 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36201 | Film No.: 251062295